171 related articles for article (PubMed ID: 32551033)
1. Effectiveness and safety of leflunomide compared with cyclophosphamide as induction therapy in Takayasu's arteritis: an observational study.
Dai X; Cui X; Sun Y; Ma L; Jiang L
Ther Adv Chronic Dis; 2020; 11():2040622320922019. PubMed ID: 32551033
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of leflunomide
Ying S; Xiaomeng C; Xiaomin D; Jiang L; Peng L; Lili M; Rongyi C; Zongfei J; Huiyong C; Lindi J
Ther Adv Musculoskelet Dis; 2020; 12():1759720X20930114. PubMed ID: 32536986
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of leflunomide treatment in Takayasu arteritis: Case series from the East China cohort.
Cui X; Dai X; Ma L; Yang C; Tan W; Zhang L; Zhang Z; Feng X; Wu R; Zou Y; Zhou Z; Lu Y; Wang Y; Wu M; Li S; Wang L; Lin H; Dong Z; Fu W; Sun X; Wang C; Ding J; Lv P; Lin J; Jiang L;
Semin Arthritis Rheum; 2020 Feb; 50(1):59-65. PubMed ID: 31350057
[TBL] [Abstract][Full Text] [Related]
4. Cyclophosphamide could be a better choice than methotrexate as induction treatment for patients with more severe Takayasu's arteritis.
Sun Y; Ma L; Ma L; Kong X; Chen H; Lv P; Lin J; Liu H; Yan Y; Ji Z; Yang C; Dai S; Wan W; Zou Y; Jin X; Jiang L
Rheumatol Int; 2017 Dec; 37(12):2019-2026. PubMed ID: 29030659
[TBL] [Abstract][Full Text] [Related]
5. Does glucocorticosteroid-resistant large-vessel vasculitis (giant cell arteritis and Takayasu arteritis) exist and how can remission be achieved? A critical review of the literature.
Kötter I; Henes JC; Wagner AD; Loock J; Gross WL
Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S114-29. PubMed ID: 22640655
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness and safety of methotrexate
Wu C; Sun Y; Cui X; Wu S; Ma L; Chen H; Yan Y; Ji Z; Liu Y; Lin J; Lv P; Chen R; Yang P; Jiang L
Ther Adv Chronic Dis; 2020; 11():2040622320975233. PubMed ID: 33294149
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the efficacy and safety of leflunomide versus placebo combined with basic prednisone therapy in patients with active disease phase of Takayasu arteritis: study protocol for a randomized, double-blinded controlled trial (Takayasu arteritis clinical trial in China: TACTIC).
Sun Y; Wu B; Zhang W; Ma L; Kong X; Chen H; Jiang L
Ther Adv Chronic Dis; 2023; 14():20406223231158567. PubMed ID: 36895331
[TBL] [Abstract][Full Text] [Related]
8. Analysis of predictive factors for treatment resistance and disease relapse in Takayasu's arteritis.
Sun Y; Ma L; Chen H; Kong X; Lv P; Dai X; Ji Z; Yang C; Dai S; Wu L; Zou Y; Lin J; Shi H; Yu Q; Jiang L
Clin Rheumatol; 2018 Oct; 37(10):2789-2795. PubMed ID: 29687289
[TBL] [Abstract][Full Text] [Related]
9. Is there a place for cyclophosphamide in the treatment of giant-cell arteritis? A case series and systematic review.
de Boysson H; Boutemy J; Creveuil C; Ollivier Y; Letellier P; Pagnoux C; Bienvenu B
Semin Arthritis Rheum; 2013 Aug; 43(1):105-12. PubMed ID: 23453684
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness and safety of adalimumab compared with leflunomide in patients with Takayasu arteritis: a retrospective cohort study.
Peron Filho F; Moreira AS; Janes ALF; de Souza AWS
RMD Open; 2024 Mar; 10(1):. PubMed ID: 38443091
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness and safety of tocilizumab in patients with refractory or severe Takayasu's arteritis: A prospective cohort study in a Chinese population.
Wu S; Kong X; Cui X; Chen H; Ma L; Dai X; Ji Z; Yan Y; Huang Q; Sun Y; Jiang L
Joint Bone Spine; 2021 Oct; 88(5):105186. PubMed ID: 33892193
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of methotrexate and leflunomide as corticoid-sparing drugs in patients with polymyalgia rheumatica.
Vinicki JP; Cusa A; Domingo D; Velasco Zamora JL; Magri S; Brigante A; Schmid MM; Ávila P; Zamora N; Sorrentino L; Rodriguez AM; Linarez M; Pisoni C; Costi C; Rodriguez Gil G; Spinetto MA; Paris VU; Perrotta N; Maliandi MDR; Rillo O; Pena C; Got J; Cavallasca J; Machado Escobar M; Iturralde C; Martire MV; Tessel R; Chocobar NS; Alarcon G
Rheumatol Adv Pract; 2024; 8(2):rkae033. PubMed ID: 38560643
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of tofacitinib versus leflunomide with glucocorticoids treatment in Takayasu arteritis: A prospective study.
Wang J; Dai X; Ma L; Wu S; Jin X; Ji Z; Chen H; Ma L; Ding Z; Jiang L; Kong X
Semin Arthritis Rheum; 2022 Aug; 55():152018. PubMed ID: 35523066
[TBL] [Abstract][Full Text] [Related]
14. Role of oral cyclophosphamide in the treatment of giant cell arteritis.
Quartuccio L; Maset M; De Maglio G; Pontarini E; Fabris M; Mansutti E; Mariuzzi L; Pizzolitto S; Beltrami CA; De Vita S
Rheumatology (Oxford); 2012 Sep; 51(9):1677-86. PubMed ID: 22627726
[TBL] [Abstract][Full Text] [Related]
15. Eurolupus cyclophosphamide plus repeated pulses of methyl-prednisolone for the induction therapy of class III, IV and V lupus nephritis.
Ruiz-Irastorza G; Dueña-Bartolome L; Dunder S; Varona J; Gomez-Carballo C; Dominguez-Cainzos J; Rodrigo-Manjon A; Bueno L; Richez C; Duffau P; Blanco P; Lazaro E
Autoimmun Rev; 2021 Oct; 20(10):102898. PubMed ID: 34274543
[TBL] [Abstract][Full Text] [Related]
16. A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of generalized Wegener's granulomatosis.
Guillevin L; Cordier JF; Lhote F; Cohen P; Jarrousse B; Royer I; Lesavre P; Jacquot C; Bindi P; Bielefeld P; Desson JF; Détrée F; Dubois A; Hachulla E; Hoen B; Jacomy D; Seigneuric C; Lauque D; Stern M; Longy-Boursier M
Arthritis Rheum; 1997 Dec; 40(12):2187-98. PubMed ID: 9416856
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of leflunomide in IgA nephropathy: a systematic review and meta-analysis.
Yi J; He Z; Xu S; Feng S
Int Urol Nephrol; 2019 Nov; 51(11):1987-1998. PubMed ID: 31515666
[TBL] [Abstract][Full Text] [Related]
18. Improved clinical outcomes of tocilizumab
Zongfei J; Lijuan Z; Ying S; Dongmei L; Sifan W; Xiufang K; Lingying M; Yun L; Lili M; Huiyong C; Lindi J
Ther Adv Chronic Dis; 2021; 12():20406223211028776. PubMed ID: 34262681
[TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy and safety of full-dose versus half-dose corticosteroids plus leflunomide for IgA nephropathy.
Li Y; Xiong Y; Huang T; Liu X; Xu G
BMC Nephrol; 2021 Nov; 22(1):364. PubMed ID: 34736419
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness of maintenance therapy with methotrexate compared with leflunomide for patients with RA having achieved disease control with both these drugs: results of a predefined sub-analysis of CareRA, a pragmatic RCT.
Stouten V; Michiels S; Westhovens R; De Cock D; Belba A; Pazmino S; Van der Elst K; Joly J; Verschueren P
Clin Rheumatol; 2020 Sep; 39(9):2593-2601. PubMed ID: 32166429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
